It has been established that the levels of certain enzymes are elevated in the serum of patients suffering from muscular dystrophy. Previous studies
dystrophy and in patients with non-hereditary myopathic disorders, as well as in a number of patients with muscular weakness and wasting of neuropathic origin, in order to delineate more precisely the diagnostic value of serum creatine kinase estimations in these conditions.
MATERIALS AND METHODS
The patients were classified according to the criteria of ' Aided by research grants from the Muscular Dystrophy Associations of America, Inc., the Muscular Dystrophy Association of Canada, and the Muscular Dystrophy Group of Great Britain. 96 Walton and Nattiass (1954) , as subsequently modified by Walton (1961) , into Duchenne, limb-girdle, and facioscapulohumeral types, and a number of cases of dystrophia myotonica were included. The non-hereditary myopathies have been subdivided into cases of polymyositis and a miscellaneous group. This latter group includes cases of myopathy associated with connective tissue disorders, metabolic diseases, and cases induced by corticosteroid drugs. The diagnosis was based on clinical data, and in any case where this was in doubt, electromyography and muscle biopsy were used to confirm the clinical diagnosis.
Physical exercise, the ingestion of food, and certain other physiological variables do not affect the serum creatine kinase level (Pearce et al., 1964) and therefore no account was taken of these factors in obtaining blood samples.
The creatine kinase activity of serum was estimated by measuring the formation of creatine from creatine phosphate and adenosine diphosphate; the details of the method have been described in a previous paper (Pearce et al., 1964) . The results are expressed as micro-moles of creatine formed per hour per millilitre of serum at 37°C.; the upper limit of normal is 3-5 units in this laboratory.
RESULTS
The results are given in Tables I to VII. In all 21 patients with Duchenne dystrophy the serum creatine kinase level was grossly elevated, values ranging from 70 to 962 units; the elevation was maximum in the younger cases of shortest duration (Fig. 1) . Four out of six cases of limb-girdle dystrophy exhibited abnormally high levels, namely, between 5 and 99 units. Of seven cases of facioscapulohumeral dystrophy, all had abnormal creatine kinase activity, varying between 3-8 and 17 units. Five out of seven cases of dystrophia myotonica had elevated creatine kinase activity, values varying from 3 9 to 9 units.
In the non-hereditary myopathies, only four out of 12 cases of polymyositis showed abnormal values, and all 17 patients with myopathy associated with connective tissue diseases, metabolic diseases, and steroid therapy had normal serum creatine kinase activity. In a series of cases of neurogenic muscle disease, the serum creatine kinase activity was normal.
DISCUSSION
From the results obtained, it is suggested that estimation of the serum creatine kinase activity is of considerable diagnostic value. The activity of this enzyme is constantly and grossly elevated in cases of Duchenne type muscular dystrophy, this elevation being maximum in the younger patients with disease of shortest duration (Fig. 1) . This is in agreement with the findings for serum aldolase in other studies (Pearson, 1957; Thompson and Vignos, 1959; Thomson et al., 1960) .
In the other inherited myopathies, the serum creatine kinase level was elevated in the majority of cases, but the elevation observed was considerably less than that found in patients with the Duchenne type of dystrophy. As Richterich and his co-workers point out (1964) In the past, elevated activities of serum transaminase and of aldolase have been observed in patients suffering from polymyositis. In the present study most cases of polymyositis had normal serum creatine kinase levels. Two children (P.D. and J.E., Table V) showed markedly elevated values, and in one man (W.M., Table V), who was being treated with prednisone, there was also a marked increase in the serum creatine kinase. It was this observation which prompted a study of enzyme activity in cases of steroid myopathies, in which group, however, we were unable to demonstrate any abnormality in serum creatine kinase. In cases of polymyositis, we were unable to find any clear-cut correlation between the chronicity or activity of the disease, and the elevation occasionally observed in serum creatine kinase. In some cases showing a normal activity of this enzyme in the serum, there was widespread muscular weakness and the disorder was comparatively acute. Both children with polymyositis exhibited high serum creatine kinase levels, and it may be that in this condition the level is more related to age than to the activity of the disease. The elevation is so infrequent in adults as to be of no diagnostic value, though a normal figure favours polymyositis as opposed to muscular dystrophy of late onset.
It has been shown by Schapira and his co-workers (1960) that although the serum aldolase and transaminases were found to be elevated in the primary myopathic disorders, these enzymes were present in normal amounts in the sera of patients with neurogenic muscular atrophy. Our results demonstrate that the serum creatine kinase activity is also normal in patients with neurogenic muscle disease, and hence is of considerable value in differentiating such patients from cases of muscular dystrophy. This accords with the findings of Pearson (1962) .
The serum transaminases are frequently elevated to equally high levels both in cases of polymyositis and in cases of muscular dystrophy. Serum aldolase is similarly often elevated in both conditions, but the levels are usually lower in polymyositis. However, differentiation between these two groups of muscle disease cannot be made with confidence on the basis of changes of the serum levels of these enzymes. The almost constant elevation of serum creatine kinase levels in cases of muscular dystrophy, compared with the occasional and comparatively small elevation which occurs in patients suffering from polymyositis, is of considerable diagnostic value in differentiating these two conditions in cases where the clinical diagnosis is in doubt. However, our findings suggest that serum creatine kinase activity is perhaps of less value in this connexion when distinguishing childhood polymyositis from dystrophy.
It is well known that intracellular enzymes may be liberated into the serum as a result of local inflammation or ischaemic necrosis. Elevations of serum creatine kinase activity may therefore be found in patients suffering from myocardial or hepatocellular disease. Recent reports (Graig and Ross, 1963; Griffiths, 1963; Saito, Hibi, Kawazura, and Fukuyama, 1963) have indicated that similar elevations are found in cases of hypothyroidism, and that the elevation may be reversed by appropriate replacement therapy (Saito et al., 1963) . The presence of the above diseases will usually be apparent from the clinical features of the individual case, and in our experience have not been a source of diagnostic difficulty in patients with primary muscular disorders.
It is important to note that the results obtained in this study must be related to the biochemical method used in estimating serum creatine kinase. Differing results have been obtained in patients with polymyositis by Richterich and his co-workers (1964) , who employed a different and more complex technique for serum assays of creatine kinase, and these results have yet to be confirmed.
The finding of increased levels of muscle enzymes in the serum is thought to represent an abnormal permeability of the muscle cell membrane which allows the enzymes to leak out into the plasma (Thomson et al., 1960; Thomson, 1962) . The highest values occur in the early stages of muscular dystrophy, and the levels decline in parallel with the diminution of functional muscle mass (Thompson and Vignos, 1959) . Almost certainly the leakage of muscle enzymes into the serum represents a secondary effect of muscle cell dysfunction, and is not of primary aetiological significance. The difference between the serum creatine kinase levels we have found in the muscular dystrophies and those recorded in the acquired myopathies is striking, and as an empirical observation is of some help in diagnosis. The significance of this finding is not immediately apparent but could reflect certain basic differences in the pathogenesis of the two groups of diseases. It seems possible that the dystrophic process, in addition to producing degeneration and necrosis of muscle cell cytoplasm and nuclei, selectively damages the muscle cell membrane; this process appears to be most marked in the most rapidly destructive variety of muscular dystrophy, namely the childhood or Duchenne type.
SUMMARY
The serum creatine kinase activity has been measured in a series of patients suffering from the common types of muscular dystrophy, and in cases of acquired myopathy. Constant elevation of serum creatine kinase activity was found in the Duchenne type cases, and smaller elevations were noted in limb-girdle and facioscapulohumeral cases and in dystrophia myotonica. In the acquired myopathies, including polymyositis, the enzyme level was usually normal except in cases of polymyositis in childhood. The diagnostic significance of these findings and certain aetiological implications are discussed.
